Share this article
NEW YORK, Jan. 13, 2021 /PRNewswire/
Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) ( Actinium ) today announced the research collaboration with Astellas Pharma Inc. (TSE:4503) ( Astellas ) to develop novel targeted radiotherapies using its Antibody Warhead Enabling (AWE) technology platform. Under this agreement, Actinium will utilize its AWE Platform technology to develop and characterize selected Astellas targeting agents labeled with the potent alpha-emitting radioisotope Actinium-225 (Ac-225). This collaboration is a component of Astellas internal initiative to develop theranostics as part of its Rx+ ® business (For more information, please visit https://www.astellas.com/en/news/16356). We are excited to execute on this research collaboration with Astellas, a global leader at the forefront of healthcare innovation, stated Dr. Dale Ludwig, Chief Scientific and Technology Officer of Actinium. Targeted radiotherapy has a highly differentiated
Doctors, drug manufacturer working on treatment plan for Kila boy in critical care
By: Sean Wells
and last updated 2021-01-08 17:59:52-05
KILA â 9-year-old Maverick Bench from Kila, a small rural town outside of Kalispell, has a rare condition called Aplastic Anemia, when the body stops producing enough new blood cells.
Maverick is still fighting for his life at the Childrenâs Hospital of Colorado outside of Denver, now in critical condition with severe liver failure.
Mavericks parents put out a plea to Mavericks Army on Facebook Wednesday asking for them to reach out to the drug company that has a potentially lifesaving drug for Maverickâs condition.
Doctors, drug manufacturer working on treatment plan for Kila boy in critical care
By: Sean Wells
and last updated 2021-01-08 10:32:02-05
KILA â 9-year-old Maverick Bench from Kila, a small rural town outside of Kalispell, has a rare condition called Aplastic Anemia, when the body stops producing enough new blood cells.
Maverick is still fighting for his life at the Childrenâs Hospital of Colorado outside of Denver, now in critical condition with severe liver failure.
Mavericks parents put out a plea to Mavericks Army on Facebook Wednesday asking for them to reach out to the drug company that has a potentially lifesaving drug for Maverickâs condition.
Sr Research Technologist/ Research Lab Specialist nature.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from nature.com Daily Mail and Mail on Sunday newspapers.
Charité und Vivantes bleiben auf Rechnungen sitzen morgenpost.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from morgenpost.de Daily Mail and Mail on Sunday newspapers.